What CorMatrix does

CorMatrix, legally operating as Corvivo, Inc. and doing business as "CorMatrix Cardiovascular," is a privately held medical device company founded in 2001 and headquartered in Roswell, Georgia. The company develops and sells biomaterial-based devices — primarily cardiovascular and soft tissue repair patches — designed to harness the body's natural ability to regenerate damaged cardiac tissue. Its core technology centers on extracellular matrix biomaterials used in cardiovascular reconstruction procedures, and the company self-positions as a "World Leader in Cardiovascular Regeneration."

The company's commercial model is a direct hardware-sales business targeting hospitals and medical institutions performing cardiovascular surgery. It reaches healthcare providers through direct sales channels supported by phone (678-566-2628) and email ([email protected]) customer service infrastructure, and uses email/newsletter registration for ongoing customer engagement. Hospitals represent the dominant end-user channel in its addressable market (44.1%), and the broader cardiovascular and soft tissue repair patches market is sized at approximately $5.2 billion in 2025, projected to reach $9.1 billion by 2032 at an 8.2% CAGR, with North America holding 38.7% regional share.

CorMatrix operates with a lean team of 51-100 employees and is led by founder-CEO and Chairman David B. Camp, alongside a small executive team covering strategy, finance, medical affairs, and sales/marketing. The company has historically funded operations through capital markets — raising approximately $55.9 million across four disclosed rounds in 2013-2015 — though no further funding activity has been recorded in over a decade, and no revenue figures, customer counts, regulatory milestones, patents, or partnerships are publicly disclosed.

Name

CorMatrix

Legal name

Corvivo, Inc.

Website

https://cormatrix.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

CorMatrix (legal entity Corvivo, Inc.) is a privately held medical device company that develops and sells biomaterial-based cardiovascular and soft tissue repair patches to hospitals and surgical centers performing cardiovascular reconstruction procedures.

Ownership category

akta.pro rank

Headquarters

HQ city

Roswell

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Cardiovascular Medical Device Sales: Revenue generated from the sale of cardiovascular and soft tissue repair patches to healthcare providers, primarily hospitals performing cardiovascular reconstruction procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CorMatrix (operating as Corvivo, Inc.) develops and sells biomaterial medical devices, principally cardiovascular and soft tissue repair patches, that leverage the body's natural ability to regenerate damaged heart and soft tissues. Its core offering targets cardiac surgeons and hospitals performing cardiovascular reconstruction, extremity vascular injury repair, and other soft tissue repair procedures.

Product overview

CorMatrix (operating as Corvivo, Inc.) is a medical technology company specializing in cardiovascular regeneration. The company appears to offer a core cardiovascular repair product line, though specific product names and detailed descriptions are limited in the available source data. Contact and news registration services are available through their website.

Differentiator

Problem solved

Functional benefit

Products and services

• CorMatrix Cardiovascular Repair Patches Biomaterial cardiovascular and soft tissue repair patches designed to harness the body's ability to regenerate damaged heart and soft tissues; sold to cardiac surgeons and hospitals for cardiovascular reconstruction, extremity vascular injury repair, and soft tissue repair procedures.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Edwards Lifesciences: Edwards Lifesciences is a global leader in structural heart and critical care. It competes with CorMatrix in cardiovascular surgery through valve repair and cardiac surgery adjunct products, making it a broad incumbent with overlapping cardiac OR customers.
• Abbott (Cardiovascular): Abbott's cardiovascular division sells a broad portfolio across structural heart, cardiac surgery, and vascular repair. It overlaps with CorMatrix's hospital customer base and competes in surgical patch and graft adjacencies as part of a much larger portfolio.
• Medtronic: Medtronic is a global cardiovascular incumbent with cardiac surgery and vascular repair offerings. It competes with CorMatrix for hospital cardiac surgery budgets and serves as a benchmark for what scaled incumbents can offer bundling surgical patches with valves and other devices.
• Getinge (Maquet): Getinge's Maquet brand sells cardiac surgery products including patches and grafts used in operating rooms. It overlaps with CorMatrix's hospital channel and competes in cardiac reconstruction consumables as part of a broader surgical portfolio.

Direct peers

• Artivion (formerly CryoLife): Artivion specializes in cardiac and vascular surgery, including tissue patches and biomaterials for cardiac repair—the most direct competitor to CorMatrix's cardiovascular regeneration patch portfolio in US hospital cardiac surgery.
• W. L. Gore & Associates (Gore Medical): Gore Medical manufactures GORE-TEX and other surgical patches widely used in cardiac and vascular reconstruction. It is a direct peer given its flagship synthetic surgical patch lines compete head-to-head with CorMatrix in the same cardiac OR procedures.
• Terumo (Terumo Aortic / Vascutek): Terumo's aortic and vascular division (including the former Vascutek and Bolton Medical lines) sells surgical grafts and patches used in cardiovascular reconstruction. It directly competes with CorMatrix in cardiac and vascular patch applications.
• LeMaitre Vascular: LeMaitre Vascular specializes in vascular and cardiac surgery disposables including patches and grafts. It is a direct peer serving the same vascular and cardiovascular reconstruction surgical procedures as CorMatrix.

Emerging players

• Anteris Technologies: Anteris is an emerging structural heart company developing regenerative tissue-engineered cardiovascular products including biomaterial scaffolds. It is an emerging peer with overlapping cardiovascular regeneration and biomaterial technology focus.
• Admedus (Anteris subsidiary, formerly Admedus Solutions): Admedus developed CardioCel and other regenerative tissue patches for cardiac and vascular repair, making it an emerging biomaterial patch peer with overlapping cardiovascular regeneration focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cormatrix-cardiovascular

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorMatrix